23andMe to Report FY2024 Third Quarter Financial Results
SOUTH SAN FRANCISCO, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq:ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial results for the fiscal year 2024 (FY2024) third quarter after the market closes on Wednesday, February 7, 2024. The Company will webcast a conference call at 4:30 p.m. Eastern Time on that date to discuss the quarter’s financial results and report on business progress.
Related news for (ME)
- Don’t Miss Out: MoBot’s Latest Stock Updates 10/20/25 10:00 AM
- Breaking News: MoBot’s Latest Update as of 10/20/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 10/17/25 07:00 PM
- MoBot alert highlights: NASDAQ: VRME, NASDAQ: ATAI, NASDAQ: STKE, NASDAQ: FGI, NASDAQ: LNKS (10/17/25 06:00 PM)
- Power Hour Pulse: Stages, Silos & Silicon Stocks in the Spotlight